Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate neuroprotection independent of HDAC inhibition

Sama F. Sleiman, David Olson, Megan W. Bourassa, Saravanan S. Karuppagounder, Yan Ling Zhang, Jennifer Gale, Florence F. Wagner, Manuela Basso, Giovanni Coppola, John T. Pinto, Edward B. Holson, Rajiv R. Ratan

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Histone deacetylase (HDAC) inhibition improves function and extends survival in rodent models of a host of neurological conditions, including stroke, and neurodegenerative diseases. Our understanding, however, of the contribution of individual HDAC isoforms to neuronal death is limited. In this study, we used selective chemical probes to assess the individual roles of the Class I HDAC isoforms in protecting Mus musculus primary cortical neurons from oxidative death.Wedemonstrated that the selectiveHDAC8inhibitor PCI-34051 is a potent neuroprotective agent; and by taking advantage of both pharmacological and genetic tools, we established that HDAC8 is not critically involved in PCI-34051’s mechanism of action.Weused BRD3811, an inactive ortholog of PCI-34051, and showed that, despite its inability to inhibit HDAC8, it exhibits robust neuroprotective properties. Furthermore, molecular deletion of HDAC8 proved insufficient to protect neurons from oxidative death, whereas both PCI-34051 and BRD3811 were able to protect neurons derived from HDAC8 knock-out mice. Finally, we designed and synthesized two new, orthogonal negative control compounds, BRD9715 and BRD8461, which lack the hydroxamic acid motif and showed that they stably penetrate cell membranes but are not neuroprotective. These results indicate that the protective effects of these hydroxamic acid-containing small molecules are likely unrelated to direct epigenetic regulation via HDAC inhibition, but rather due to their ability to bind metals. Our results suggest that hydroxamic acid-based HDAC inhibitors may mediate neuroprotection via HDAC-independent mechanisms and affirm the need for careful structure–activity relationship studies when using pharmacological approaches.

Original languageEnglish (US)
Pages (from-to)14328-14337
Number of pages10
JournalJournal of Neuroscience
Volume34
Issue number43
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Hydroxamic Acids
Histone Deacetylase Inhibitors
Histone Deacetylases
Neurons
Protein Isoforms
Pharmacology
Neuroprotective Agents
Epigenomics
Knockout Mice
Neurodegenerative Diseases
Rodentia
Metals
Stroke
Cell Membrane
Neuroprotection
PCI 34051

Keywords

  • HDAC inhibitors
  • HDAC8
  • Hydroxamic acids
  • Neuroprotection
  • Oxidative stress
  • PCI-34051

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate neuroprotection independent of HDAC inhibition. / Sleiman, Sama F.; Olson, David; Bourassa, Megan W.; Karuppagounder, Saravanan S.; Zhang, Yan Ling; Gale, Jennifer; Wagner, Florence F.; Basso, Manuela; Coppola, Giovanni; Pinto, John T.; Holson, Edward B.; Ratan, Rajiv R.

In: Journal of Neuroscience, Vol. 34, No. 43, 01.01.2014, p. 14328-14337.

Research output: Contribution to journalArticle

Sleiman, SF, Olson, D, Bourassa, MW, Karuppagounder, SS, Zhang, YL, Gale, J, Wagner, FF, Basso, M, Coppola, G, Pinto, JT, Holson, EB & Ratan, RR 2014, 'Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate neuroprotection independent of HDAC inhibition', Journal of Neuroscience, vol. 34, no. 43, pp. 14328-14337. https://doi.org/10.1523/JNEUROSCI.1010-14.2014
Sleiman, Sama F. ; Olson, David ; Bourassa, Megan W. ; Karuppagounder, Saravanan S. ; Zhang, Yan Ling ; Gale, Jennifer ; Wagner, Florence F. ; Basso, Manuela ; Coppola, Giovanni ; Pinto, John T. ; Holson, Edward B. ; Ratan, Rajiv R. / Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate neuroprotection independent of HDAC inhibition. In: Journal of Neuroscience. 2014 ; Vol. 34, No. 43. pp. 14328-14337.
@article{08df037ecdab469399ee0a4c96c28970,
title = "Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate neuroprotection independent of HDAC inhibition",
abstract = "Histone deacetylase (HDAC) inhibition improves function and extends survival in rodent models of a host of neurological conditions, including stroke, and neurodegenerative diseases. Our understanding, however, of the contribution of individual HDAC isoforms to neuronal death is limited. In this study, we used selective chemical probes to assess the individual roles of the Class I HDAC isoforms in protecting Mus musculus primary cortical neurons from oxidative death.Wedemonstrated that the selectiveHDAC8inhibitor PCI-34051 is a potent neuroprotective agent; and by taking advantage of both pharmacological and genetic tools, we established that HDAC8 is not critically involved in PCI-34051’s mechanism of action.Weused BRD3811, an inactive ortholog of PCI-34051, and showed that, despite its inability to inhibit HDAC8, it exhibits robust neuroprotective properties. Furthermore, molecular deletion of HDAC8 proved insufficient to protect neurons from oxidative death, whereas both PCI-34051 and BRD3811 were able to protect neurons derived from HDAC8 knock-out mice. Finally, we designed and synthesized two new, orthogonal negative control compounds, BRD9715 and BRD8461, which lack the hydroxamic acid motif and showed that they stably penetrate cell membranes but are not neuroprotective. These results indicate that the protective effects of these hydroxamic acid-containing small molecules are likely unrelated to direct epigenetic regulation via HDAC inhibition, but rather due to their ability to bind metals. Our results suggest that hydroxamic acid-based HDAC inhibitors may mediate neuroprotection via HDAC-independent mechanisms and affirm the need for careful structure–activity relationship studies when using pharmacological approaches.",
keywords = "HDAC inhibitors, HDAC8, Hydroxamic acids, Neuroprotection, Oxidative stress, PCI-34051",
author = "Sleiman, {Sama F.} and David Olson and Bourassa, {Megan W.} and Karuppagounder, {Saravanan S.} and Zhang, {Yan Ling} and Jennifer Gale and Wagner, {Florence F.} and Manuela Basso and Giovanni Coppola and Pinto, {John T.} and Holson, {Edward B.} and Ratan, {Rajiv R.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1523/JNEUROSCI.1010-14.2014",
language = "English (US)",
volume = "34",
pages = "14328--14337",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "43",

}

TY - JOUR

T1 - Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate neuroprotection independent of HDAC inhibition

AU - Sleiman, Sama F.

AU - Olson, David

AU - Bourassa, Megan W.

AU - Karuppagounder, Saravanan S.

AU - Zhang, Yan Ling

AU - Gale, Jennifer

AU - Wagner, Florence F.

AU - Basso, Manuela

AU - Coppola, Giovanni

AU - Pinto, John T.

AU - Holson, Edward B.

AU - Ratan, Rajiv R.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Histone deacetylase (HDAC) inhibition improves function and extends survival in rodent models of a host of neurological conditions, including stroke, and neurodegenerative diseases. Our understanding, however, of the contribution of individual HDAC isoforms to neuronal death is limited. In this study, we used selective chemical probes to assess the individual roles of the Class I HDAC isoforms in protecting Mus musculus primary cortical neurons from oxidative death.Wedemonstrated that the selectiveHDAC8inhibitor PCI-34051 is a potent neuroprotective agent; and by taking advantage of both pharmacological and genetic tools, we established that HDAC8 is not critically involved in PCI-34051’s mechanism of action.Weused BRD3811, an inactive ortholog of PCI-34051, and showed that, despite its inability to inhibit HDAC8, it exhibits robust neuroprotective properties. Furthermore, molecular deletion of HDAC8 proved insufficient to protect neurons from oxidative death, whereas both PCI-34051 and BRD3811 were able to protect neurons derived from HDAC8 knock-out mice. Finally, we designed and synthesized two new, orthogonal negative control compounds, BRD9715 and BRD8461, which lack the hydroxamic acid motif and showed that they stably penetrate cell membranes but are not neuroprotective. These results indicate that the protective effects of these hydroxamic acid-containing small molecules are likely unrelated to direct epigenetic regulation via HDAC inhibition, but rather due to their ability to bind metals. Our results suggest that hydroxamic acid-based HDAC inhibitors may mediate neuroprotection via HDAC-independent mechanisms and affirm the need for careful structure–activity relationship studies when using pharmacological approaches.

AB - Histone deacetylase (HDAC) inhibition improves function and extends survival in rodent models of a host of neurological conditions, including stroke, and neurodegenerative diseases. Our understanding, however, of the contribution of individual HDAC isoforms to neuronal death is limited. In this study, we used selective chemical probes to assess the individual roles of the Class I HDAC isoforms in protecting Mus musculus primary cortical neurons from oxidative death.Wedemonstrated that the selectiveHDAC8inhibitor PCI-34051 is a potent neuroprotective agent; and by taking advantage of both pharmacological and genetic tools, we established that HDAC8 is not critically involved in PCI-34051’s mechanism of action.Weused BRD3811, an inactive ortholog of PCI-34051, and showed that, despite its inability to inhibit HDAC8, it exhibits robust neuroprotective properties. Furthermore, molecular deletion of HDAC8 proved insufficient to protect neurons from oxidative death, whereas both PCI-34051 and BRD3811 were able to protect neurons derived from HDAC8 knock-out mice. Finally, we designed and synthesized two new, orthogonal negative control compounds, BRD9715 and BRD8461, which lack the hydroxamic acid motif and showed that they stably penetrate cell membranes but are not neuroprotective. These results indicate that the protective effects of these hydroxamic acid-containing small molecules are likely unrelated to direct epigenetic regulation via HDAC inhibition, but rather due to their ability to bind metals. Our results suggest that hydroxamic acid-based HDAC inhibitors may mediate neuroprotection via HDAC-independent mechanisms and affirm the need for careful structure–activity relationship studies when using pharmacological approaches.

KW - HDAC inhibitors

KW - HDAC8

KW - Hydroxamic acids

KW - Neuroprotection

KW - Oxidative stress

KW - PCI-34051

UR - http://www.scopus.com/inward/record.url?scp=84908065243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908065243&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.1010-14.2014

DO - 10.1523/JNEUROSCI.1010-14.2014

M3 - Article

C2 - 25339746

AN - SCOPUS:84908065243

VL - 34

SP - 14328

EP - 14337

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 43

ER -